Daiichi Sankyo seeks Japanese approval for Enhertu to treat patients with HER2 positive metastatic solid tumours: Tokyo Friday, April 25, 2025, 09:00 Hrs [IST] Daiichi Sankyo has ...

Atezolizumab may improve upon perioperative treatment with trastuzumab and chemotherapy in HER2+, locally advanced, resectable gastric or GEJ cancer, researchers say.

1 Human epidermal growth factor receptor 2 (HER2/ErbB2) overexpression, the most studied member of the type I receptor tyrosine kinase family, is present in up to 25% of women with breast cancer ...

Cogent Biosciences (COGT) announced preclinical data from four pipeline programs during poster sessions at the American Association for Cancer ...

whose tumors have activating HER2 (ERBB2) mutations, as detected by an FDA-approved test, and who have received a prior systemic therapy This indication is approved under accelerated approval ...

The trial involved 12 patients with locally advanced stage I-III HER2 breast cancer ... Dendritic Cells Before Chemotherapy in ERBB2 Breast Cancer, JAMA Oncology (2024). DOI: 10.1001/jamaoncol.